Abnormal glucose homeostasis in patients of HbEβ-thalassemia: Prevalence and possible pathogenesis using the Oxford HOMA model
Journal of Hematology and Allied Sciences · 2022
DOI: 10.25259/jhas_13_2022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Hematology and Allied Sciences, 2022. Verfasst von Ankita Sen und 5 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben.
Abstract (Originalsprache)
Objectives
Eβ-thalassemia, the most serious form of HbE syndromes, may develop pre-diabetes (PD) and diabetes mellitus (DM), together constituting abnormal glucose homeostasis (AGH) as an endocrinopathy. This study aims to assess AGH prevalence and pathogenesis in this thalassemia subtype. Material and Methods: A cross-sectional study was conducted at a tertiary care hospital from February 2017 to December 2018 (1.9 years). One hundred and four HbEβ-thalassemia patients were randomly selected aged ≥5 years, irrespective of transfusion requirement. AGH was diagnosed by the American Diabetes Association criteria. The patient’s history, relevant examination details, and parameters related to glucose homeostasis were studied. The homeostasis assessment (HOMA) model of Oxford University was used, and formulae were applied to calculate HOMA-insulin resistance (IR) or HOMA-β (β-cell function).
Results
The status of glucose homeostasis was as follows: Normal glucose homeostasis tolerance 83/104(79.8%), PD 20/104(19.2%), and DM one(1%). The patient’s age, age of starting transfusions, and HOMA-IR were significantly related to AGH. AGH was inversely associated with the age of starting chelation, though not significant ( P = 0.07). There was no statistical significance of AGH development, with transfusion dependence ( P = 0.63), family history of DM ( P = 0.42), hepatitis C ( P = 0.36), and higher ferritin levels (800/1000/1500/1700 ng/ml) ( P > 0.5)/HOMA-β ( P > 0.5).
Conclusion
HbEβ-thalassemia patients are prone to develop AGH including overt diabetes. It is related to the patient’s age, age of initiation, and duration of transfusion therapy. The likely mechanism of pathogenesis is IR, though pancreatic β-cell destruction may also be contributory.
Zitieren
APA
Sen, A., Sahana, P. K., Chakrabarti, P., Ghosh, P., Dolai, T. K., & De, R. (2022). Abnormal glucose homeostasis in patients of HbEβ-thalassemia: Prevalence and possible pathogenesis using the Oxford HOMA model. Journal of Hematology and Allied Sciences. https://doi.org/10.25259/jhas_13_2022
Vancouver
Sen A, Sahana PK, Chakrabarti P, Ghosh P, Dolai TK, De R. Abnormal glucose homeostasis in patients of HbEβ-thalassemia: Prevalence and possible pathogenesis using the Oxford HOMA model. Journal of Hematology and Allied Sciences. 2022. doi:10.25259/jhas_13_2022
BibTeX
@article{Sen2022,
author = {Sen, Ankita and Sahana, Pranab Kumar and Chakrabarti, Prantar and Ghosh, Pramit and Dolai, Tuphan Kanti and De, Rajib},
title = {Abnormal glucose homeostasis in patients of HbEβ-thalassemia: Prevalence and possible pathogenesis using the Oxford HOMA model},
journal = {Journal of Hematology and Allied Sciences},
year = {2022},
doi = {10.25259/jhas_13_2022}
}
EUVIMED